nasal cavities or paranasal sinuses.
The reason why polyps develop in some patients and not in others remains unknown; nasal polyps consist ofconnective tissue, edema and inflammatory cells such as eosinophils (the most common), neutrophils, mast cells, plasma cells, lymphocytes and monocytes. Nasal polyps have a strong tendency to relapse after functional endoscopic sinus surgery (FESS), suggesting different pathogenic mechanisms underlying CRS with and without nasal polyps (CRSwNP and CRSsNP) (4) (5) . Actually nasal polyps have been associated with IL5, local nasal IgE production, eosinophils, eotaxin, and eosinophil cationic protein (ECP) (Th2 driven disease), whereas in CRSsNP a less defined Th2 profile, neutrophil infiltration, INFy and TGFp production have been reported (6) (7) .
The epithelial cell-derived thymic stromal Iymphopoietin (TSLP) has been recently identified as a key factor in Th2-inflammatory response: it is a cytokine which is mainly expressed by epithelial cells in the thymus, lung, skin, intestine and tonsils. Its expression may be induced by different exogenous/endogenous stimuli, as well as pathogens, traumas, infections, allergens, Toll Like Receptor Ligands (TLR-ligands), pro-inflammatory and Th2 cytokines (8) .
TSLP receptor (TSLP R) is expressed on several immune cel1s, such as dendritic cells (DCs), B cells, T cells, mast cells, natural killer-T (NK-T) and monocytes, and on many organ tissues such as heart, skeletal muscle, kidney and liver. The receptor is a heterodimeric complex made up of two chains, TSLP Rand IL7Ra and its phosphorilation activates STAT5 pathway (8) .
TSLP endows DCs to induce the differentiation of inflammatory Th2 cells up-regulating co-stimulatory molecules (CD40, CD80), MHC II molecules and OX40 ligand (OX40L) (8) (9) (10) . A pathogenetic role of TSLP in some Th2 driven diseases like asthma (11-12) and atopic dermatitis (AD) (13-16) have been recently suggested.
Our hypothesis is that TSLP may play an important role also in CRS pathogenesis, where epithelial barrier of sinus mucosal surface may initiate inflammatory response by secreting various cytokines and chemokines, which regulate innate immune cells.
Increased levels of TSLP in nasal mucosa of patients affected by allergic rhinitis have been reported by Mou (17) (18) and, in a recent study, Liu et al. showed high levels ofTSLP in nasal epithelial layer of patients with nasal polyps (19) .
In the present study we wanted to investigate whether the expression of TSLP receptor was increased in patients with CRS compared to controls and whether there was a difference in TSLP R expression in CRSwNP compared to CRSsNP. To this end, the expression of TSLP R was analyzed by immunohystochemical technique on surgical specimens of sinus biopsies obtained from patients affected by CRSwNP and CRSsNP and from controls (subjects who underwent cosmetic rhinoplasty).
MATERIALS AND METHODS

Patients
Between January and July 20 I0 at the First ENT Division of the University of Turin-Italy, 15 consecutive Caucasian patients (10 male: 67%; and 5 female: 33%) with a mean age of 51.46±13 years (range 34-78 years) affected by chronic rhino-sinusitis (CRS) with and without nasal polyps were enrolled in this prospective study which was approved by the local research committee (Table I) (Table II) . The allergic status of all patients was investigated by means of cutaneous prick and patch tests.
Each patient was firstly treated with at least one cycle of oral antibiotics (penicillin/cephalosporin/ fluoroquinolones), oral steroids (metilprednisone) associated with intranasal corticosteroids (mometasone furoate, fluticasone furoate, budesonide) and nasal washing. After treatment failure all the patients were recruited for surgical intervention. No patients had been surgically treated previously.
Surgical treatment consisted in functional endoscopic sinus surgery (FESS), in order to erase the polyps and to clear all the involved paranasal sinuses. The procedural technique was that described by Graz School (20) . Biopsy specimens were collected from ostio-meatal complex mucosa in patients affected by CRSsNP, from nasal polyp in patients with CRSwNP and from nasal respiratory mucosa of the control group (subjects who had undergone cosmetic rhinoplasty or who had uncorrelated pathologies, obtained from the Pathological Anatomy Division of the University of Turin); all specimens were immediately placed in a 10% buffered formalin solution, routinely processed, and embedded in paraffin; 4-~m-thick consecutive sections were cut for the study.
Immunohistochemistry
Samples were deparaffinized in xylene and rehydrated in a series of graded alcohols. The sections were treated with a 3% solution of HP2 for 30 minutes to inhibit endogenous peroxidase activity. Non specific binding sites were blocked by pre-incubation with fetal bovine serum for 25 minutes at room temperature. Reacted tissue sections were then incubated with I00~I of polyclonal goat anti-human TSLP R (R&D System, Abingdon, UK; dilution I:6,6) for 1.5 h at room temperature.
The primary antibody was replaced by fetal bovine serum in negative controls, whereas normal human liver specimens were used as positive controls.
Biotinylated rabbit-antigoat IgG (H+L) was obtained from Sigma (Sigma Pharmaceutical Ltd., South Croydon, Australia), and the avidin-biotin peroxidase complex kit was from DAKO LSAB (Dako, Carpinteria, Calif). The sections were then treated for 30 min at room temperature with biotinylated rabbit-antigoat immunoglobulin (dilution I:2000), followed by incubation with avidinbiotin peroxidase complex solution for 15 min and diaminobenzidine tetrahydrochloride as chromogen. The slides were finally counterstained with Mayer's hematoxylin for 5 seconds, dehydrated, and mounted in Clarion (Biomeda, Foster City, California). Healthy nasal mucosa samples were used as control group and analysed as described for the CRS specimens.
Interpretation ofimmunohistochemical stains
TSLP R expression was interpreted semi-quantitatively evaluating the specimens at three different levels: the inflammatory infiltrates, the respiratory epithelium and the stromal/fibroblastic component (connective tissue), using a grade for each level: grade 0 (1-10% of positive cells), grade I (11-25% of positive cells), grade 2 (26-50% of positive cells), grade 3 (51-75% of positive cells), grade 4 (76-100% of positive cells). After detecting the intensity of the inflammatory infiltrates, the staining intensity for the three cell types was scored as 0 (negative), I (weak), 2 (medium), and 3 (strong). The immunoreactivity score was determined by multiplying staining intensity score by grade score (intensity x grade score: maximum immunostaining score (IS) 12).
Statistical analyses
All statistical analyses were carried out using GraphPad Prism 4. For normal distribution data, oneway ANOYA was used for determining the statistical significance of differences in TSLP R expression in the inflammatory infiltrates and respiratory epithelial cells among CRSwNP, CRSsNP and the control group (probability value of p<0.05 was considered statistically significant). For non-normal distribution, one-way ANOYA with Kruskal-Wallis test was performed. Furthermore, multiple comparison analysis was always performed by the Student's r-test adopting the Bonferroni method to have a stricter criterion on whether to accept an N umber of patients ( · Nasal blockage, congestion or stuffiness; · Nasal discharge or postnasal drip, often mucopurulent;
· Facial pain or pressure, headache, and · Reduction/loss of smell.
Physical examination
· Anterior rhinoscopy · Endoscopy · Imaging (facial bones CT scan)
Fig. 1. TSLP R immunostaining. Nasal mucosa from healthy subjects (A-B): negative staining in epithelial and irfiammatory cells; nasal mucosa from CRSsNP subjects (C-D): intense staining density interesting the epithelial layer and the inflammatory infiltrate, black arrows indicate the massive epithelial cells staining and the intlammatory cells staining: (original magnification x200).
effect as significant (p<O.OI6).
RESULTS
In sinus bioptic samples of CRS patients eosinophilic infiltration with scattered mast cells and histiocytes was present, compared to a few lymphocytes in healthy controls.
TSLP R expression was evaluated separately in inflammatory infiltrate, respiratory epithelium, and connective tissue (stromal cells and fibroblasts). apical granular cytoplasmic staining in epithelial cells and as widespread granular cytoplasmic staining in inflammatory cells underlying respiratory epithelium (Fig. 1) . In a few pathological specimens, a Golgian dot like staining was observed in inflammatory cells (Fig. 2 ).
. TSLP R immunostaining. Nasal polyps from CRSwNP subjects: intense staining grade in epithelial cells (black arrows in panel A) and in the inflammatory infiltrate (black arrow in panel B), (original magnification x200); inflammatory infiltrate ofnasal polyps from CRSwNP subjects (C-D): black arrows show the Golgian dot like positivity in inflammatory cells (original magnification x400).~~J
An increased percentage of TSLP R positive cells was observed in inflammatory and epithelial cells of CRSwNP and CRSsNP compared to control group (54.5±5.9%, 38.4±8.1% and 5.3±3.8%, p< 0.0001 positive inflammatory cells and 66.1±6.6%, 66±12.4%, 7.7±4.3%, p< 0.0001 positive epithelial cells respectively). No significant difference was observed between CRSwNP and CRSsNP in either inflammatory or epithelial cells (Fig. 3) .
Immunostaining score (IS) (staining intensity x Fig. 4, panel A and B ). TSLP R expression could not be appreciated at all, or the staining intensity was very low in the connective tissue of all the groups (Fig. 4, panel C) .
DISCUSSION
Our results show that TSLP R is barely expressed in normal sinus tissue, whereas it is highly expressed in CRS, both in inflammatory and epithelial cells, with no significant difference between CRS subtypes (CRSwNP and CRSsNP). The cells with the highest TSLP R immunostaining score were eosinophils, mast cells and histiocytes in accordance with the data reported by Allakhverdi and coIl. who showed that eosinophiIs and mast cells express the functional TSLP R complex and are able to respond to TSLP signals in the presence of inflammatory environment in a dose-dependent manner (21) (22) (23) . We did not observe any TSLP receptor immunostaining in the connective tissue either in CRS or in healthy controls. Our results suggest a leading role of epithelial cells in addressing inflammatory response towards a Th2 pattern, as supported by the highest TSLP R expression observed in eosinophils and mast cells.
We found that TSLP R was equally highly expressed in CRSwNP and CRSsNP, suggesting a common pathway in the inflammatory response which starts from the epithelial barrier and through TSLP-TSLP R interaction drives the nasal mucosa through a Th2-inflammatory response. In our series we could not note any difference in the inflammatory infiltrate, which was mainly eosinophilic, either in CRSwNP or in CRSsNP. The pathogenetic mechanisms, which lead to the development of nasal polyps, are still unknown and probably involve different cytokines, like TNFa or ILl p, and growth factors. Transforming growth factor-beta (TGFP) has been implicated as an important factor in remodeling processes involved in chronic sinus disease, and plays as a main switch for different remodeling patterns in chronic sinus disease (24) .
To our knowledge, no previous report has investigated the TSLP R expression in CRS patients with or without nasal polyps.
In conclusion, this study suggests a critical role for TSLP as a driving factor in the pathogenesis of CRS, supported by the massive presence of its receptor both in the inflammatory cells and epithelial layer. The emerging concept oftissue-specific control of immunity, with TSLP secretion at the epithelial level acting as an initial factor in the CRS cascade, can partially explain the early stages of the disease. Further studies on the immune mechanisms involved in nasal polyps formation are required.
